vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and LandBridge Co LLC (LB). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $56.8M, roughly 1.5× LandBridge Co LLC). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 14.2%, a 8.6% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 55.6%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 72.8%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
FDMT vs LB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $56.8M |
| Net Profit | $19.4M | $8.1M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 60.0% |
| Net Margin | 22.8% | 14.2% |
| Revenue YoY | 8508900.0% | 55.6% |
| Net Profit YoY | 139.1% | -83.7% |
| EPS (diluted) | $0.43 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $56.8M | ||
| Q3 25 | $90.0K | $50.8M | ||
| Q2 25 | $15.0K | $47.5M | ||
| Q1 25 | $14.0K | $44.0M | ||
| Q4 24 | $1.0K | $36.5M | ||
| Q3 24 | $3.0K | $28.5M | ||
| Q2 24 | $5.0K | $26.0M | ||
| Q1 24 | $28.0K | $19.0M |
| Q4 25 | $19.4M | $8.1M | ||
| Q3 25 | $-56.9M | $8.1M | ||
| Q2 25 | $-54.7M | $7.5M | ||
| Q1 25 | $-48.0M | $6.5M | ||
| Q4 24 | — | $49.3M | ||
| Q3 24 | $-43.8M | $2.7M | ||
| Q2 24 | $-35.0M | $-57.7M | ||
| Q1 24 | $-32.4M | $10.8M |
| Q4 25 | 17.3% | 60.0% | ||
| Q3 25 | -67983.3% | 60.8% | ||
| Q2 25 | -396373.3% | 60.0% | ||
| Q1 25 | -383007.1% | 57.0% | ||
| Q4 24 | — | 49.4% | ||
| Q3 24 | -1704400.0% | 11.2% | ||
| Q2 24 | -849120.0% | -197.4% | ||
| Q1 24 | -136200.0% | 71.1% |
| Q4 25 | 22.8% | 14.2% | ||
| Q3 25 | -63195.6% | 15.9% | ||
| Q2 25 | -364386.7% | 15.8% | ||
| Q1 25 | -342657.1% | 14.7% | ||
| Q4 24 | — | 135.2% | ||
| Q3 24 | -1461433.3% | 9.3% | ||
| Q2 24 | -699060.0% | -222.1% | ||
| Q1 24 | -115717.9% | 56.7% |
| Q4 25 | $0.43 | $0.24 | ||
| Q3 25 | $-1.01 | $0.26 | ||
| Q2 25 | $-0.98 | $0.24 | ||
| Q1 25 | $-0.86 | $0.20 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.79 | $-0.04 | ||
| Q2 24 | $-0.63 | — | ||
| Q1 24 | $-0.66 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $30.7M |
| Total DebtLower is stronger | — | $570.7M |
| Stockholders' EquityBook value | $505.7M | $340.3M |
| Total Assets | $566.7M | $1.4B |
| Debt / EquityLower = less leverage | — | 1.68× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $30.7M | ||
| Q3 25 | $305.1M | $28.3M | ||
| Q2 25 | $293.2M | $20.3M | ||
| Q1 25 | $321.4M | $14.9M | ||
| Q4 24 | $424.9M | $37.0M | ||
| Q3 24 | $501.9M | $14.4M | ||
| Q2 24 | $541.9M | $24.6M | ||
| Q1 24 | $525.9M | — |
| Q4 25 | — | $570.7M | ||
| Q3 25 | — | $366.1M | ||
| Q2 25 | — | $370.9M | ||
| Q1 25 | — | $375.5M | ||
| Q4 24 | — | $385.5M | ||
| Q3 24 | — | $242.4M | ||
| Q2 24 | — | $360.8M | ||
| Q1 24 | — | — |
| Q4 25 | $505.7M | $340.3M | ||
| Q3 25 | $369.0M | $272.0M | ||
| Q2 25 | $420.9M | $266.4M | ||
| Q1 25 | $469.7M | $217.0M | ||
| Q4 24 | $510.6M | $211.8M | ||
| Q3 24 | $552.9M | $97.2M | ||
| Q2 24 | $588.3M | $296.4M | ||
| Q1 24 | $600.6M | $162.3M |
| Q4 25 | $566.7M | $1.4B | ||
| Q3 25 | $424.0M | $1.1B | ||
| Q2 25 | $473.6M | $1.1B | ||
| Q1 25 | $515.7M | $1.0B | ||
| Q4 24 | $560.4M | $1.0B | ||
| Q3 24 | $604.0M | $689.9M | ||
| Q2 24 | $620.1M | $710.5M | ||
| Q1 24 | $629.9M | — |
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.35× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.73× | ||
| Q4 24 | — | 1.82× | ||
| Q3 24 | — | 2.49× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $126.3M |
| Free Cash FlowOCF − Capex | $28.5M | $122.0M |
| FCF MarginFCF / Revenue | 33.5% | 214.9% |
| Capex IntensityCapex / Revenue | 0.1% | 7.5% |
| Cash ConversionOCF / Net Profit | 1.47× | 15.68× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $207.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $126.3M | ||
| Q3 25 | $-46.5M | $34.9M | ||
| Q2 25 | $-43.4M | $37.3M | ||
| Q1 25 | $-47.8M | $15.9M | ||
| Q4 24 | $-134.6M | $67.6M | ||
| Q3 24 | $-29.4M | $7.5M | ||
| Q2 24 | $-30.2M | $16.0M | ||
| Q1 24 | $-29.1M | $17.2M |
| Q4 25 | $28.5M | $122.0M | ||
| Q3 25 | $-46.6M | $33.7M | ||
| Q2 25 | $-43.4M | $36.1M | ||
| Q1 25 | $-48.4M | $15.8M | ||
| Q4 24 | $-138.4M | $66.7M | ||
| Q3 24 | $-31.2M | $7.1M | ||
| Q2 24 | $-30.6M | $15.7M | ||
| Q1 24 | $-29.8M | $17.1M |
| Q4 25 | 33.5% | 214.9% | ||
| Q3 25 | -51765.6% | 66.3% | ||
| Q2 25 | -289620.0% | 75.9% | ||
| Q1 25 | -345635.7% | 36.0% | ||
| Q4 24 | -13837100.0% | 182.6% | ||
| Q3 24 | -1038966.7% | 25.1% | ||
| Q2 24 | -611840.0% | 60.4% | ||
| Q1 24 | -106421.4% | 90.1% |
| Q4 25 | 0.1% | 7.5% | ||
| Q3 25 | 101.1% | 2.3% | ||
| Q2 25 | 440.0% | 2.6% | ||
| Q1 25 | 4507.1% | 0.2% | ||
| Q4 24 | 378600.0% | 2.7% | ||
| Q3 24 | 59266.7% | 1.1% | ||
| Q2 24 | 6980.0% | 1.4% | ||
| Q1 24 | 2535.7% | 0.5% |
| Q4 25 | 1.47× | 15.68× | ||
| Q3 25 | — | 4.31× | ||
| Q2 25 | — | 4.98× | ||
| Q1 25 | — | 2.46× | ||
| Q4 24 | — | 1.37× | ||
| Q3 24 | — | 2.80× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
